Neuromyelitis Optica Market Fueled by Biologic Therapy Advances

σε πρόσθεσε στο Health

2025-04-30 11:03:44 -

The Neuromyelitis Optica (NMO) market centers on a spectrum of targeted immunotherapies designed to prevent debilitating relapses, preserve neurological function and improve quality of life in patients with this rare autoimmune disorder. Key products include monoclonal antibodies such as eculizumab, satralizumab and inebilizumab, which inhibit complement activation or block interleukin-6...

0 Σχόλια 0 Μοιράστηκε 58 Views 0 Προεπισκόπηση